Literature DB >> 25048522

Blood culture time to positivity in febrile infants with bacteremia.

Eric A Biondi1, Matthew Mischler2, Karen E Jerardi3, Angela M Statile3, Jason French4, Rianna Evans5, Vivian Lee6, Clifford Chen7, Carl Asche8, Jinma Ren2, Samir S Shah9.   

Abstract

IMPORTANCE: Blood cultures are often obtained as part of the evaluation of infants with fever and these infants are typically observed until their cultures are determined to have no growth. However, the time to positivity of blood culture results in this population is not known.
OBJECTIVE: To determine the time to positivity of blood culture results in febrile infants admitted to a general inpatient unit. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, retrospective, cross-sectional evaluation of blood culture time to positivity. Data were collected by community and academic hospital systems associated with the Pediatric Research in Inpatient Settings Network. The study included febrile infants 90 days of age or younger with bacteremia and without surgical histories outside of an intensive care unit. EXPOSURES: Blood culture growing pathogenic bacteria. MAIN OUTCOMES AND MEASURES: Time to positivity and proportion of positive blood culture results that become positive more than 24 hours after placement in the analyzer.
RESULTS: A total of 392 pathogenic blood cultures were included from 17 hospital systems across the United States. The mean (SD) time to positivity was 15.41 (8.30) hours. By 24 hours, 91% (95% CI, 88-93) had turned positive. By 36 and 48 hours, 96% (95% CI, 95-98) and 99% (95% CI, 97-100) had become positive, respectively. CONCLUSIONS AND RELEVANCE: Most pathogens in febrile, bacteremic infants 90 days of age or younger hospitalized on a general inpatient unit will be identified within 24 hours of collection. These data suggest that inpatient observation of febrile infants for more than 24 hours may be unnecessary in most infants.

Entities:  

Mesh:

Year:  2014        PMID: 25048522     DOI: 10.1001/jamapediatrics.2014.895

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  19 in total

Review 1.  Diagnosis of Bloodstream Infections in Children.

Authors:  Jennifer Dien Bard; Erin McElvania TeKippe
Journal:  J Clin Microbiol       Date:  2016-01-27       Impact factor: 5.948

2.  Time to Pathogen Detection for Non-ill Versus Ill-Appearing Infants ≤60 Days Old With Bacteremia and Meningitis.

Authors:  Paul L Aronson; Marie E Wang; Lise E Nigrovic; Samir S Shah; Sanyukta Desai; Christopher M Pruitt; Fran Balamuth; Laura Sartori; Richard D Marble; Sahar N Rooholamini; Rianna C Leazer; Christopher Woll; Adrienne G DePorre; Mark I Neuman
Journal:  Hosp Pediatr       Date:  2018-07

3.  Impact of Enteroviral Polymerase Chain Reaction Testing on Length of Stay for Infants 60 Days Old or Younger.

Authors:  Paul L Aronson; Todd W Lyons; Andrea T Cruz; Stephen B Freedman; Pamela J Okada; Alesia H Fleming; Joseph L Arms; Amy D Thompson; Suzanne M Schmidt; Jeffrey Louie; Michael J Alfonzo; Michael C Monuteaux; Lise E Nigrovic
Journal:  J Pediatr       Date:  2017-07-10       Impact factor: 4.406

Review 4.  Medication and Fluid Management of Pediatric Sepsis and Septic Shock.

Authors:  Lauren Burgunder; Caroline Heyrend; Jared Olson; Chanelle Stidham; Roni D Lane; Jennifer K Workman; Gitte Y Larsen
Journal:  Paediatr Drugs       Date:  2022-03-21       Impact factor: 3.022

5.  [Effect of improvement in antibiotic use strategy on the short-term clinical outcome of preterm infants with a gestational age of <35 weeks].

Authors:  Mei-Yan Chu; Ming-Jie Wang; Jin Lin; Ge Yang; Ying Ding; Zheng-Chang Liao; Chuan-Ding Cao; Shao-Jie Yue
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

6.  Empiric Antibiotic Use and Susceptibility in Infants With Bacterial Infections: A Multicenter Retrospective Cohort Study.

Authors:  Elana A Feldman; Russell J McCulloh; Angela L Myers; Paul L Aronson; Mark I Neuman; Miranda C Bradford; Elizabeth R Alpern; Frances Balamuth; Mercedes M Blackstone; Whitney L Browning; Katie Hayes; Rosalynne Korman; Rianna C Leazer; Lise E Nigrovic; Richard Marble; Emily Roben; Derek J Williams; Joel S Tieder
Journal:  Hosp Pediatr       Date:  2017-07-20

7.  Time to Positive Blood and Cerebrospinal Fluid Cultures in Febrile Infants ≤60 Days of Age.

Authors:  Elizabeth R Alpern; Nathan Kuppermann; Stephen Blumberg; Genie Roosevelt; Andrea T Cruz; Lise E Nigrovic; Lorin R Browne; John M VanBuren; Octavio Ramilo; Prashant Mahajan
Journal:  Hosp Pediatr       Date:  2020-09

8.  Optimizing the Use of Antibacterial Agents in the Neonatal Period.

Authors:  Joseph B Cantey
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

9.  Rhinovirus in Febrile Infants and Risk of Bacterial Infection.

Authors:  Anne J Blaschke; E Kent Korgenski; Jacob Wilkes; Angela P Presson; Emily A Thorell; Andrew T Pavia; Elizabeth D Knackstedt; Carolyn Reynolds; Jeff E Schunk; Judy A Daly; Carrie L Byington
Journal:  Pediatrics       Date:  2018-01-17       Impact factor: 7.124

10.  Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009.

Authors:  Emily L Mueller; Kelly J Walkovich; Rajen Mody; Achamyeleh Gebremariam; Matthew M Davis
Journal:  BMC Cancer       Date:  2015-05-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.